Cargando…

BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint

The B cell-specific transcription factor BACH2 is required for affinity maturation of mature B cells. Here, we show that Bach2-mediated activation of p53 is required for stringent elimination of pre-B cells that failed to productively rearrange immunoglobulin V(H)-DJ(H) gene segments. Upon productiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaminathan, Srividya, Huang, Chuanxin, Geng, Huimin, Chen, Zhengshan, Harvey, Richard, Kang, Huining, Ng, Carina, Titz, Björn, Hurtz, Christian, Sadiyah, Mohammed Firas, Nowak, Daniel, Thoennissen, Gabriela B., Rand, Vikki, Graeber, Thomas G., Koeffler, H. Phillip, Carroll, William L, Willman, Cheryl L, Hall, Andrew G., Igarashi, Kazuhiko, Melnick, Ari, Müschen, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954721/
https://www.ncbi.nlm.nih.gov/pubmed/23852341
http://dx.doi.org/10.1038/nm.3247
Descripción
Sumario:The B cell-specific transcription factor BACH2 is required for affinity maturation of mature B cells. Here, we show that Bach2-mediated activation of p53 is required for stringent elimination of pre-B cells that failed to productively rearrange immunoglobulin V(H)-DJ(H) gene segments. Upon productive V(H)-DJ(H) gene rearrangement, pre-B cell receptor signaling ends negative selection through BCL6-mediated repression of p53. In patients with pre-B ALL, BACH2-mediated checkpoint control is frequently compromised. Low levels of BACH2 expression represent a strong independent predictor of poor clinical outcome. Bach2(+/+) pre-B cells resist leukemic transformation by Myc through Bach2-dependent upregulation of p53, and fail to initiate fatal leukemia in transplant recipient mice. ChIP-seq and gene expression analyses reveal that BACH2 competes with BCL6 for promoter binding and reverses BCL6-mediated repression of p53 and other checkpoint control genes. These findings identify Bach2 as a critical mediator negative selection at the pre-B cell receptor checkpoint and a safeguard against leukemogenesis.